Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03363373
Title Naxitamab for Neuroblastoma With Osteomedullary Disease
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Y-mAbs Therapeutics
Indications

neuroblastoma

Therapies

Naxitamab + Sargramostim

Age Groups: child | senior | adult
Covered Countries USA | CAN


No variant requirements are available.